Treatment of calf deep venous thrombosis

American Family Physician

Volumn 71, Issue 11, 2005, Pages 2157-2158

  Rotert, Eric M ^a   Basarich, John R ^a   Nashelsky, Joan ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Family Practice Inquiries Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; COST CONTROL; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG COMPRESSION; LEG THROMBOSIS; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SHORT SURVEY; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ANTICOAGULANTS; HUMANS; LEG; RISK FACTORS; VENOUS THROMBOSIS;

EID: 20444398183     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Evidence Report/Technology Assessment No. 68. AHRQ Publication No. 03-E012. Rockville, Md.: Agency for Healthcare Research and Quality, January 2003. Accessed online March 25, 2005, at: http://www.ahrq.gov/clinic/epcsums/dvtsum. htm.
2. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985;2:515-8.
3. Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, et al. Investigators of the "Duree Optimale du Traitement AntiVitamines K" (DOTAVK) study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001;103:2453-60.
4. van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2004;(4):CD001100.
5. Schraibman IG, Milne AA, Royle EM. Home versus inpatient treatment for deep vein thrombosis. Cochrane Database Syst Rev 2001;(2):CD003076.
6. Kolbach DN, Sandbrink MW, Hamulyak K, Neumann HA, Prins MH. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2003;(3):CD004174.
7. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [published correction appears in Chest 2005;127:416]. Chest 2004;126(3 suppl):S401-28.
8. Institute for Clinical Systems Improvement. Health care guideline: thromboembolism. 5th ed. Bloomington, Minn.: 2004. Accessed online March 25, 2005, at: http://www.icsi.org/knowledge/detail.asp?catID=29& itemID=202.